Marijuana in the management of amyotrophic lateral sclerosis
@article{Carter2001MarijuanaIT,
title={Marijuana in the management of amyotrophic lateral sclerosis},
author={Gregory T Carter and B S Rosen},
journal={American Journal of Hospice and Palliative Medicine},
year={2001},
volume={18},
pages={264 - 270}
}Marijuana has been proposed as treatment for a widening spectrum of medical conditions. Marijuana is a substance with many properties that may be applicable to the management of amyotrophic lateral sclerosis (ALS). These include analgesia, muscle relaxation, bronchodilation, saliva reduction, appetite stimulation, and sleep induction. In addition, marijuana has now been shown to have strong antioxidative and neuroprotective effects, which may prolong neuronal cell survival. In areas where it is…
Tables from this paper
52 Citations
Survey of cannabis use in patients with amyotrophic lateral sclerosis
- Psychology, MedicineThe American journal of hospice & palliative care
- 2004
Results indicate that cannabis may be moderately effective at reducing symptoms of appetite loss, depression, pain, spasticity, and drooling and ineffective in reducing difficulties with speech and swallowing, and sexual dysfunction.
Medical marijuana: emerging applications for the management of neurologic disorders.
- MedicinePhysical medicine and rehabilitation clinics of North America
- 2004
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?
- BiologyNeural regeneration research
- 2016
A short but important overview of evidences that are useful to better characterize the efficacy as well as the molecular pathways modulated by cannabinoids are provided.
Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials
- BiologyThe American journal of hospice & palliative care
- 2010
Based on the currently available scientific data, it is reasonable to think that cannabis might significantly slow the progression of ALS, potentially extending life expectancy and substantially reducing the overall burden of the disease.
Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.
- MedicineNeurologic clinics
- 2015
Current pharmacological management of amyotropic lateral sclerosis and a role for rational polypharmacy
- Medicine, Biology
- 2004
Based on the available data, it is the opinion that combination drug therapies should be considered for future clinical trials.
Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis
- BiologyBioDrugs
- 2012
Gene transfer of VEGF or glial cell-line derived neurotrophic factor, anti-inflammatory COX-2 inhibitors, and minocycline have had particularly promising results in mice.
Cannabis therapy in neurological disorders: Recent advances and perspectives
- Medicine, Psychology
- 2020
Although there are clinical studies supporting the use of cannabis preparations as adjuvant therapy in neurological disorders, more investigations are needed to assess their safety and efficacy.
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
- Psychology, MedicineAddiction Science & Clinical Practice
- 2015
There is insufficient evidence to support the recommendation of medical marijuana for the treatment of the most common medical and psychological conditions for which it has been allowed at the state level.
PHARMACOTHERAPY OF AMYOTROPHIC LATERAL SCLEROSIS: AN INSIGHT
- Medicine, Biology
- 2019
Current therapeutic approaches including recent advances in pharmacological treatment strategies along with nutrition and dietary supplements based on the potential to delay onset of disease, retard the progression of Disease, extend the lifespan and improve the quality of life of patients are reviewed.
References
SHOWING 1-10 OF 76 REFERENCES
Marijuana: medical implications.
- PsychologyAmerican family physician
- 1999
Adverse effects from marijuana use include decreased coordination, epithelial damage to the lungs, increased risk of infection, cardiovascular effects and cognitive deficits.
Medicinal marijuana: a comprehensive review.
- MedicineJournal of psychoactive drugs
- 1998
A comprehensive literature review of the topic found that patients who are best suited to medicinal marijuana will be those who will gain substantial benefit to offset these risks, and who have failed a well-documented, compliant and comprehensive approach to standard therapies.
Comprehensive management of amyotrophic lateral sclerosis.
- Medicine, PsychologyPhysical medicine and rehabilitation clinics of North America
- 1998
Expanding the role of hospice care in amyotrophic lateral sclerosis
- Medicine, PsychologyThe American journal of hospice & palliative care
- 1999
There is a great need to increase awareness of both patients and clinicians regarding the effectiveness of hospice in the care of advanced ALS patients, because hospice services are far underutilized in this setting.
Marijuana, receptors and immunomodulation.
- Biology, MedicineAdvances in experimental medicine and biology
- 1995
It has recently been shown that THC can enhance production or release of pro-inflammatory cytokines, including augmented release of IL1, TNF alpha, and IL6 activity.
Endocannabinoids and vascular function.
- Biology, ChemistryThe Journal of pharmacology and experimental therapeutics
- 2000
Two arachidonic acid analogs, N-arachidonylethanolamine and 2-arACHidonylglycerol are hypothesized to function as endogenous ligands of the CB(1) receptor, and they are the subjects of this review.
Medicinal Uses of Marijuana
- PsychologyAnnals of Internal Medicine
- 1997
This purported review of the literature clearly supports continued listing of crude marijuana on schedule 1, while allowing its synthetic analogue, Marinol, to be legally prescribed on schedule 2, and Voth and Schwartz's perspective on medicinal use of marijuana is significant.